期刊文献+

英国药物警戒检查简介及启示 被引量:4

Overview of Pharmacovigilance Inspection in UK
下载PDF
导出
摘要 为促进药品安全第一责任人即药品生产企业上市后监测责任的落实,英国于2003年启动了药物警戒检查项目,目前已经形成了一套完整的检查体系。通过对英国药物警戒检查类型、检查流程、检查结果等内容介绍,提出了对我国生产企业药品不良反应报告和监测的检查分工、检查指南、自我检查指标体系以及信息沟通方面的思考和建议。 To promote pharmaceutical manufacturer, the first person for products safety to undertake post-marketing surveillance responsibility,UK initiated pharmacovigilance inspection programme in 2003, and now it formed a set of complete inspection system.This article introduced pharmacovigilance inspection type, process, findings and so on in UK, and proposed recommendation on adverse drug reaction report and monitoring inspection responsiblity division, guideline, self-checking indicatior system and information communication.
出处 《中国药物警戒》 2014年第8期478-481,共4页 Chinese Journal of Pharmacovigilance
关键词 英国 药物警戒 药品不良反应 检查 UK pharmacovigilance adverse drug reaction inspection
  • 相关文献

参考文献13

  • 1MHRA.Guidance Notes on the Information Requested For anMHRAStatutory Pharmacovigilance Inspection [EB/OL].(2013-04-01)[ 2014-07-22 ].http://www,mhra.gov.uk/home/groups/is-insp/documents/websiteresources/con057172.pdf.
  • 2.罗氏不良反应事件大量数据仍未公开[EB/OL].新浪财经http://finance.sina.com.cn/roll/20120716/072512573757.shtml,(2012-07-16)[2014-07-22].
  • 3国家食品药品监督管理局.《药品不良反应报告和监测管理办法》修订发布[EB/OL].(2011-5-24)[2014-07-22].http://www.sda.gov.cn/WS01/CL0051/62634.html.
  • 4MHRA.Types of inspections [EB/OL].(2013-07-18)[2014-07-22].http://www.mhra.gov.uk/Howweregulate/Medicines/Inspectio- nandstandards/GoodPharmacovigilancePrac.
  • 5董铎,孙利华,杨晓茹.欧盟药物警戒检查制度简介[J].中国新药杂志,2012,21(8):832-835. 被引量:5
  • 6MHRA.GoodPharmacovigilance Practice:Thelnspection Process [EB/OL].(2013-07-18)[2014-07-22].http://www.mhra.gov.uk/Howweregulate/Medicines/Inspectionandstandards/GoodPharma- covigilancePractice/Theinspectionprocess/index.htm(2014-07-22).
  • 7MHRA.Overview of the Pharmacovigilance Inspection Progress [EB/OL].(2008-02-04)[2014-07-22].http://www.mhra.gov.uk/home/groups/is-insp/documents/websiteresources/con013899.pps.
  • 8MHRA.Part II:SPS Template[EB/OL].(2010-10-01)[2014-07-22].http://www.mhra.gov.uk/home/groups/is-insp/documents/web- siteresources/con2018030.doc.
  • 9MHRA.Frequently asked questions for Good Pharmacovigilance Practice [EB/OL].(2013-O9-2 4)[2014-O7-22]http'.//wwwa-nhr~tgov.uk/Howweregulate/Medicines/Inspectionandstandards/GoodPha- rmacovl tlyaskedquestions/index.htm#5.
  • 10MHRA.Inspection report and company response process[EB/OL][2014-07-22].http://www.mhm.gov Inspectionandstandards/GoodPharmacovigilancePractice/Thein- spectionprocess/index.htm.

二级参考文献6

  • 1European Commission.Directive 2001/83/EC of the Europeanparliament and council of 6 November 2001on the Community coderelating to medicinal products for human use. http://www.ema.europa.eu/docs/en_GB/document_library/Regulatory_and_procedural_guideline/2009/10/WC500004481.pdf . 2011
  • 2European Medicines Agency.Procedure for the preparation of arisk-based programme for routine pharmacovigilance inspections ofMAHs connected with human centrally authorized products. http://www.ema.eu-ropa.eu/Inspections/docs/phv/10550408en.pdf . 2009
  • 3European Medicines Agency.Guideline on monitoring of compliancewith pharmacovigilance regulatory obligations and pharmacovigi-lance inspections.. http://ec.eu-ropa.eu/health/files/pharmacos/docs/doc2006/02_2006/v9_compliance-guideline_pubcons_03-2006_en.pdf . 2011
  • 4European Medicines Agency.Pharmacovigilance Inspection Policyfor Centralised Procedures-Medicinal Products for Human Use. http://www.ema.europa.eu/docs/en_GB/document_library/Regulatory_and_procedural_guideline/2009/12/WC500020068.pdf . 2009
  • 5VOLUME9A of The Rules Governing Medicinal Products in the European Union Guidelines on Pharmacovigilance for Medi-cinal Products for Human Use. http://ec.europa.eu/enterprise/pharmaceuticals/eudralex/vol-9/pdf/vol9a . 2009
  • 6颜敏,兰奋,叶国庆.《药品不良反应报告和监测管理办法》修订要点和释义[J].药物流行病学杂志,2011,20(6):273-275. 被引量:24

共引文献4

同被引文献23

引证文献4

二级引证文献41

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部